The two treatment groups were well balanced with respect to baseline characteristics, including mean age, mean weight,
and mean body mass index
and mean body mass index
| Characteristic | Eliquis® (apixaban) (N = 1157) |
Enoxaparin (N = 1130) |
|---|---|---|
| Female sex — % (n) | 59.6 (689) | 60.0 (678) |
| Mean age — years (range) | 66.1 (26 – 93) | 65.5 (33 – 87) |
| Mean weight — kg (range) | 86.7 (46.5 – 163.7) | 86.6 (40.5 – 163.3) |
| Mean body mass index — kg/m2 (range) | 30.9 (18.1 – 54.7) | 30.9 (17.7 – 51.6) |
| Race — % (n) | ||
| White | 95.8 (1108) | 95.2 (1076) |
| Black | 2.9 (33) | 3.0 (34) |
| Asian | 0.6 (7) | 1.2 (14) |
| Other | 0.8 (9) | 0.5 (6) |
| Estimated creatinine clearance > 60 mL/min — % (n) |
86.3 (999) | 87.7 (991) |
* Primary efficacy population.
